Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing emerging technological platforms related to drug metabolism and pharmacokinetics (DMPK), or safety. One‑year projects will be funded up to JPY 5,000,000 or equivalent amount, including indirect costs.
Projects should address one of four areas:
REF#10 Development of biosensors for pharmacokinetic evaluation. Specifically, platforms that enable: (i) drug monitoring in microenvironments such as capillaries and CSF space, or (ii) evaluation...